- Home
- PFBC vs TOVX Comparison
PFBC vs TOVX Comparison
Compare PFBC & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFBC
- TOVX
- Stock Information
- Founded
- PFBC 1991
- TOVX 2001
- Country
- PFBC United States
- TOVX United States
- Employees
- PFBC N/A
- TOVX N/A
- Industry
- PFBC Major Banks
- TOVX Biotechnology: Pharmaceutical Preparations
- Sector
- PFBC Finance
- TOVX Health Care
- Exchange
- PFBC Nasdaq
- TOVX Nasdaq
- Market Cap
- PFBC 1.2B
- TOVX 3.5M
- IPO Year
- PFBC 1998
- TOVX 2006
- Fundamental
- Price
- PFBC $85.96
- TOVX $1.14
- Analyst Decision
- PFBC Buy
- TOVX Strong Buy
- Analyst Count
- PFBC 2
- TOVX 1
- Target Price
- PFBC $99.50
- TOVX $6.00
- AVG Volume (30 Days)
- PFBC 73.1K
- TOVX 96.3K
- Earning Date
- PFBC 01-22-2025
- TOVX 11-12-2024
- Dividend Yield
- PFBC 3.23%
- TOVX N/A
- EPS Growth
- PFBC N/A
- TOVX N/A
- EPS
- PFBC 9.99
- TOVX N/A
- Revenue
- PFBC $260,387,999.00
- TOVX N/A
- Revenue This Year
- PFBC N/A
- TOVX N/A
- Revenue Next Year
- PFBC N/A
- TOVX N/A
- P/E Ratio
- PFBC $8.55
- TOVX N/A
- Revenue Growth
- PFBC N/A
- TOVX N/A
- 52 Week Low
- PFBC $66.88
- TOVX $1.14
- 52 Week High
- PFBC $99.78
- TOVX $17.00
- Technical
- Relative Strength Index (RSI)
- PFBC 33.01
- TOVX 36.15
- Support Level
- PFBC $90.71
- TOVX $1.23
- Resistance Level
- PFBC $93.26
- TOVX $1.21
- Average True Range (ATR)
- PFBC 2.38
- TOVX 0.07
- MACD
- PFBC -1.28
- TOVX 0.01
- Stochastic Oscillator
- PFBC 12.51
- TOVX 0.00
About PFBC Preferred Bank
Preferred Bank is a commercial bank located in California. Its products and services are divided into Personal Banking, Business Banking, and Commercial Banking which includes Checking accounts, Savings accounts, CDs, Loans and Credit, Electronic banking and Treasury Management. It provides personalized deposit services, real estate finance, commercial loans, and trade finance credit facilities to small and mid-sized businesses and their owners, entrepreneurs, real estate developers and investors, professionals and high-net-worth individuals. The bank generates a majority of its revenue from Southern and Northern California and Flushing.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.